MedTrace Logo

Predicting Factors for Mortality in Congenital Heart Disease Patients After Shunt Procedure in Developing Country.

NCT05800691 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 197

Last updated 2023-08-08

No results posted yet for this study

Summary

Blalock Taussig (BT) is a palliative procedure that preserves blood circulation to the lungs and alleviates cyanosis in patients with congenital heart diseases and reduced pulmonary blood flow. BT shunt remains a routinely performed procedure in developing countries before definitive surgery. However, evidence on predictors factors of mortality after this procedure is still scarce in Indonesia.

Conditions

  • Cyanotic Congenital Heart Disease

Sponsors & Collaborators

  • Indonesia University

    collaborator OTHER

  • Universitas Sumatera Utara

    lead OTHER

Eligibility

Min Age
1 Day
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2021-01-31
Completion
2021-01-31

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05800691 on ClinicalTrials.gov